(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS CANINIZADOS PARA NGF HUMANO

Em AnáliseInvention PatentPCT · EP2022086091

Application data

Invention Patent ANTICORPOS CANINIZADOS PARA NGF HUMANO de INTERVET INTERNATIONAL B.V. — IPC A61P 19/02
Invention Patent ANTICORPOS CANINIZADOS PARA NGF HUMANO de INTERVET INTERNATIONAL B.V. — IPC A61P 19/02. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024011853

Type

Invention Patent

Filing

12/15/2022

Publication

09/10/2024

PCT

EP2022086091

Progress at the INPI

  1. Filing12/15/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 12/15/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/10/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

INTERVET INTERNATIONAL B.V.

NL

See this company's full portfolio

Inventors

M. M. (pessoa física)

US

Y. Z. (pessoa física)

US

Technical data

Priority claims

US

63/290,264 · 12/16/2021

US

63/327,076 · 04/04/2022

Abstract

ANTICORPOS CANINIZADOS PARA NGF HUMANO.A presente invenção fornece anticorpos NGF anti-humano caninizados que têm uma alta afinidade de ligação ao NGF canino. A invenção também está relacionada ao uso desses anticorpos no tratamento de dor em caninos e outros animais de companhia.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

09/10/2024

RPI 2801

Alteração de dados cadastrais

#1.1

06/25/2024

RPI 2790

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.